ANLAdlai Nortye Ltd. American Depositary Shares
13.70USDMkt Cap: 882.25M $P/E: —3d ago
Adlai Nortye Group Ltd., a clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products. Its product pipeline comprises AN0025, a small molecule EP4 antagonist whic…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap882.25M $
Enterprise Value676.14M $
Revenue (TTM)18.06M $
Gross Profit18.06M $
Net Income (TTM)-35.53M $
Revenue/Share0.4530 USD
Last Price13.70 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees109
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-46.71
PEG—
EV/EBITDA-31.23
EV/Revenue37.45
P/S48.86
P/B-65.87
EPS (TTM)-0.66
EPS (Forward)-0.29
52W Range
13.5224% of range14.28
52W High14.28 USD
52W Low13.52 USD
Profitability
Gross Margin100.00%
Oper. Margin-44.19%
EBITDA Margin-119.91%
Profit Margin-710.56%
ROE426.92%
ROA-103.18%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-33.45M $
CapEx (TTM)187.00K $
FCF Margin-63.41%
FCF Yield-1.30%
Net Debt-206.12M $
Net Debt/EBITDA9.52
Balance Sheet
Debt/Equity-3.17
Current Ratio9.55
Quick Ratio9.24
Book Value/Sh-0.2080 USD
Cash/Share3.615 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.60 USD
Upside (mean)+108.8%
Target Range20.00 USD – 46.00 USD
$20.00+108.8% to mean$46.00
# Analysts5
Ownership
Shares Out.58.73M
Float44.78M
Insiders0.57%
Institutions45.19%
Short Interest
Short Ratio17.7d
Short % Float7.17%
Short % Out.6.48%
Shares Short4.17M
Short (prev mo.)3.34M
Technical
SMA 5011.79 (+16.2%)
SMA 2008.362 (+63.8%)
Beta1.12
S&P 52W Chg19.18%
Avg Vol (30d)103.04K
Avg Vol (10d)139.23K
Technical Indicators
RSI (14)58.3
MACD0.5422
MACD Signal0.5395
MACD Hist.+0.0027
BB Upper14.33 USD
BB Middle13.19 USD
BB Lower12.05 USD
BB Width17.36%
ATR (14)1.045 USD
Vol Ratio (20d)0.64x